Mission

          

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DIS&L is an agency created for the international development of Scrambler Therapy ® Technology, a medical device for the treatment of chronic neuropathic and oncologic pain  resistant to opiates and other types of treatment, including implanted devices.

The Scrambler Therapy® device is a U.S. FDA 510(k)-cleared and European CE mark-certified pain therapy medical device. This medical device has been developed in Italy by Prof. Giuseppe Marineo.

Scrambler Therapy ® Technology MC-5A device (FDA Clearance: # K142666 for Delta International Services & Logistics), replacing the previous old version, known in the US as the Calmare device.

DIS&L through its law firm is the only company authorized to sign international exclusive agreements in all international area, provide maintenance and distributor support for method usage training and other logistics needs. To request a national exclusive agreement the candidate distributor must have minimum requirements listed on the “distributor requirement” page.